Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd.
Explore linked clinical trials.11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial to See if Daridorexant Can Help Adults and Elderly People With Insomnia Sleep Better During the Night and Function Better During the Day | Insomia Disorder | Not yet recruiting | Phase 3 | 2026-09-28 | NCT07843329 | |
| A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fabry disease, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Nutritional and Metabolic Diseases, X-linked disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hereditary disease, inborn errors of metabolism, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, nervous system disorder, sphingolipidosis, vascular disorder | Active, not recruiting | Phase 3 | 2026-08-31 | NCT03737214 | |
| A Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry Disease | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fabry disease, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Nutritional and Metabolic Diseases, X-linked disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hereditary disease, inborn errors of metabolism, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, nervous system disorder, sphingolipidosis, vascular disorder | Not yet recruiting | Phase 3 | 2026-08-21 | NCT07778667 | |
| IMPACT-HTN Study of Patients With Hypertension | cardiovascular disorder, hypertensive disorder, vascular disorder | Not yet recruiting | Not stated | 2026-06-29 | NCT07579260 | |
| A Study to Learn How Safe ACT-777991 is and How Well it Works in Adults With Non-segmental Vitiligo | Non-Segmental Vitiligo | Not yet recruiting | Phase 2 | 2026-06-25 | NCT07667569 | |
| Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease | Alzheimer disease, Dyssomnias, Sleep Disorders, Intrinsic, Sleeplessness, brain disorder, central nervous system disorder, cognitive disorder, dementia, insomnia, nervous system disorder, neurodegenerative disease, psychiatric disorder, sleep-wake disorder, tauopathy | Recruiting | Phase 4 | 2026-06-25 | NCT05924425 | |
| Department of Defense PTSD Adaptive Platform Trial - Intervention B - Vilazodone | Stress Disorders, Traumatic, acute stress disorder, post-traumatic stress disorder, psychiatric disorder | Not yet recruiting | Phase 2 | 2026-05-20 | NCT05948579 | |
| Efficacy and Safety of Daridorexant in Patients With Major Depressive Disorder and Insomnia | Dyssomnias, Sleep Disorders, Intrinsic, depressive disorder, insomnia, major depressive disorder, mood disorder, nervous system disorder, psychiatric disorder, sleep-wake disorder | Not yet recruiting | Phase 4 | 2026-04-29 | NCT07555743 | |
| Daridorexant for Alcohol Use Disorder | Alcohol Use Disorder, Chemically-Induced Disorders, alcohol-related disorders, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 2 | 2026-04-20 | NCT07532252 | |
| Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ® | Dyssomnias, Sleep Disorders, Intrinsic, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder | Recruiting | Not stated | 2025-12-02 | NCT06498128 | |
| Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant) | Dyssomnias, Sleep Disorders, Intrinsic, Sleeplessness, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder | Active, not recruiting | Not stated | 2025-08-19 | NCT06393504 |